“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says ...

The trade-off between affordability and availability in pharmaceuticals arises because decisions affecting medicines’ prices also impact their market availability. Higher prices can increase supply by ...

Blockchain is poised to redefine pharmaceutical validation, offering unparalleled improvements in data integrity, compliance, ...

A world where hospitals never run out of critical medicines, retail stores always have the right seasonal products in stock, ...

Authorities are planning stricter penalties for retailers and wholesalers as part of efforts to clean up the pharma supply ...

To promote and strengthen Nigeria’s capacity to manufacture vaccines, medicines, and other health products, the European ...

Mintz’s Pharmacy Benefits and PBM Contracting Practice is pleased to present the ‘Fourth Edition: Q1 2025’ of our Mintz IRA ...

Uba Sani, Governor of Kaduna State has inaugurated a multi-million naira pharmaceutical warehouse in the Makera area of ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

The Pharmaceutical Excipients Market is poised for significant growth between 2025 and 2035, driven by the increasing demand for drug formulations and advancements in the pharmaceutical industry.

Achieving Universal Health Coverage (UHC) in Bangladesh remains a challenge due to the high out-of-pocket healthcare costs, particularly for medicines.